Bactiguard Holding AB (publ) (STO:BACTI.B)

Sweden flag Sweden · Delayed Price · Currency is SEK
16.80
+1.15 (7.35%)
At close: Dec 5, 2025
-51.59%
Market Cap 588.74M
Revenue (ttm) 217.83M
Net Income (ttm) -21.28M
Shares Out 35.04M
EPS (ttm) -0.61
PE Ratio n/a
Forward PE 56.95
Dividend n/a
Ex-Dividend Date n/a
Volume 4,837
Average Volume 64,599
Open 15.50
Previous Close 15.65
Day's Range 15.50 - 16.85
52-Week Range 13.60 - 53.80
Beta 0.39
RSI 40.33
Earnings Date Feb 5, 2026

About Bactiguard Holding AB

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2005
Employees 177
Stock Exchange Nasdaq Stockholm
Ticker Symbol BACTI.B
Full Company Profile

Financial Performance

In 2024, Bactiguard Holding AB's revenue was 243.68 million, an increase of 19.46% compared to the previous year's 203.99 million. Losses were -29.82 million, -78.45% less than in 2023.

Financial Statements

News

Bactiguard Holding AB (STU:5JE) Q3 2025 Earnings Call Highlights: Navigating Challenges with ...

Bactiguard Holding AB (STU:5JE) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth

6 weeks ago - GuruFocus

Q3 2025 Bactiguard Holding AB Earnings Call Transcript

Q3 2025 Bactiguard Holding AB Earnings Call Transcript

6 weeks ago - GuruFocus